PharmacoEconomics & Outcomes News 341 - 1 Dec 2001 Global trends in drug spending In the first half of this year, state pharmaceutical spending in Italy increased by nearly 37% over the same period last year, reaching L11.64 billion * ($US5.4 billion), according to Scrip. 1 Abolishing the country’s patient copayment system earlier this year was, for the most part, responsible for the rise in spending, based on estimates from Ministry of Health data. A 19% rise in the number of prescriptions written over the same period was also credited with contributing to the spending increase. The biggest contributor by therapeutic category was cardiovascular drugs (up 32%), while spending on antimicrobials dropped by 2%. In Iran, pharmaceutical sales reached $US422.2 million for the year ending March 2001 – a 32% increase on the previous year. 2 Sales by therapeutic category were highest for anti-infectives, followed by central nervous system and gastrointestinal products. And in the Czech Republic, approximately $US1.03 billion was spent by consumers on pharmaceuticals in 2000, representing about 20% of spending on healthcare by this group, reports Marketletter. 3 * Italian lire 1. Italian spending up 36.5%. Scrip : 5, No. 2696, 16 Nov 2001. 2. Iranian 2001 pharma sales. Scrip : 16, No. 2695, 14 Nov 2001. 3. Czech Republic drug spending in 2000. Marketletter 28: 11, 19 Nov 2001. 800840870 1 PharmacoEconomics & Outcomes News 1 Dec 2001 No. 341 1173-5503/10/0341-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Global trends in drug spending

Download PDF Report

Upload
dinhkiet
View
215
Download
0

Embed Size (px)

Citation preview

PharmacoEconomics & Outcomes News 341 - 1 Dec 2001

Global trends in drug spendingIn the first half of this year, state pharmaceutical

spending in Italy increased by nearly 37% over the sameperiod last year, reaching L11.64 billion* ($US5.4billion), according to Scrip.1

Abolishing the country’s patient copayment systemearlier this year was, for the most part, responsible forthe rise in spending, based on estimates from Ministryof Health data. A 19% rise in the number of prescriptionswritten over the same period was also credited withcontributing to the spending increase. The biggestcontributor by therapeutic category was cardiovasculardrugs (up 32%), while spending on antimicrobialsdropped by 2%.

In Iran, pharmaceutical sales reached $US422.2million for the year ending March 2001 – a 32% increaseon the previous year.2 Sales by therapeutic categorywere highest for anti-infectives, followed by centralnervous system and gastrointestinal products. And inthe Czech Republic, approximately $US1.03 billion wasspent by consumers on pharmaceuticals in 2000,representing about 20% of spending on healthcare bythis group, reports Marketletter.3

* Italian lire

1. Italian spending up 36.5%. Scrip : 5, No. 2696, 16 Nov 2001.2. Iranian 2001 pharma sales. Scrip : 16, No. 2695, 14 Nov 2001.3. Czech Republic drug spending in 2000. Marketletter 28: 11, 19 Nov 2001.

800840870